Repligen (RGEN) Financials

$127.59 +1.40 (+1.11%)

As of 05/20/2025 04:00 PM Eastern

Annual Income Statements for Repligen

This table shows Repligen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-26	36	186	128	60	21	17	28	221	9.35
Consolidated Net Income / (Loss)	-26	36	186	128	60	21	17	28	12	9.35
Net Income / (Loss) Continuing Operations	-26	36	186	128	60	21	17	28	221	9.35
Total Pre-Tax Income	-27	57	219	154	59	26	21	7.25	12	13
Total Operating Income	-35	48	225	167	70	36	26	14	16	14
Total Gross Profit	275	278	456	391	210	151	108	74	162	48
Total Revenue	634	632	802	671	366	270	194	141	209	84
Operating Revenue	634	632	802	671	366	270	194	141	209	84
Total Cost of Revenue	360	354	346	279	157	119	87	67	47	35
Operating Cost of Revenue	360	354	346	279	157	119	87	67	47	35
Total Operating Expenses	310	231	231	224	140	115	82	60	-63	35
Selling, General & Admin Expense	263	219	216	184	120	96	66	52	31	25
Research & Development Expense	43	43	44	34	20	19	16	8.67	7.36	5.74
Other Special Charges / (Income)	3.19	-31	-29	5.87	-	-	-	-	3.24	4.08
Total Other Income / (Expense), net	8.08	9.00	-5.53	-14	-11	-9.93	-4.55	-6.76	-4.28	-0.34
Interest Expense	21	15	1.16	11	11	15	6.71	6.44	3.77	0.03
Interest & Investment Income	36	24	6.98	0.18	1.74	5.32	1.90	0.37	0.35	0.14
Other Income / (Expense), net	-7.02	0.05	-11	-2.60	-1.58	-0.31	0.26	-0.69	-0.86	-0.45
Income Tax Expense	-1.52	21	33	25	-0.71	4.74	4.82	-21	0.01	4.08
Basic Earnings per Share	($0.46)	$0.64	$3.35	$2.33	$1.14	$0.44	$0.38	$0.74	$0.35	$0.28
Weighted Average Basic Shares Outstanding	55.94M	55.72M	55.46M	55.02M	52.55M	48.34M	43.77M	38.23M	33.57M	32.88M
Diluted Earnings per Share	($0.46)	$0.63	$3.24	$2.24	$1.11	$0.44	$0.37	$0.72	$0.34	$0.28
Weighted Average Diluted Shares Outstanding	55.94M	56.38M	57.46M	57.26M	53.89M	49.21M	45.47M	39.15M	34.10M	33.58M
Weighted Average Basic & Diluted Shares Outstanding	56.15M	55.77M	55.56M	55.33M	54.77M	52.08M	43.70M	38.30M	33.40M	33.40M

This table shows Repligen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	5.83	-34	-0.65	5.71	3.30	-16	17	20	15	49	40
Consolidated Net Income / (Loss)	5.83	-34	-0.65	5.71	3.30	-16	17	20	15	49	40
Net Income / (Loss) Continuing Operations	5.83	-34	-0.65	5.71	3.30	-16	17	20	15	49	40
Total Pre-Tax Income	7.94	-39	-1.15	9.03	3.70	1.87	11	25	19	53	47
Total Operating Income	6.58	-37	-7.83	5.47	3.75	9.87	4.69	19	14	49	53
Total Gross Profit	91	39	77	82	77	78	37	80	84	96	114
Total Revenue	169	168	155	159	153	167	141	159	165	187	201
Operating Revenue	169	168	155	159	153	167	141	159	165	187	201
Total Cost of Revenue	78	129	77	77	76	88	105	79	82	91	87
Operating Cost of Revenue	78	129	77	77	76	88	105	79	82	91	87
Total Operating Expenses	84	75	85	76	73	69	32	61	70	47	62
Selling, General & Admin Expense	71	60	76	65	62	58	56	49	56	53	54
Research & Development Expense	13	12	9.71	11	11	10	11	9.71	12	11	10
Other Special Charges / (Income)	0.00	3.19	0.00	0.00	0.00	0.70	-34	1.79	1.24	-17	-2.31
Total Other Income / (Expense), net	1.37	-2.11	6.68	3.56	-0.06	-8.01	6.69	5.62	4.70	4.15	-5.20
Interest Expense	5.25	5.46	5.12	5.12	5.03	14	0.41	0.41	0.41	0.27	0.33
Interest & Investment Income	7.31	8.29	9.13	9.41	8.99	6.02	6.66	5.96	5.49	4.02	2.18
Other Income / (Expense), net	-0.70	-4.94	2.68	-0.74	-4.02	-0.08	0.44	0.07	-0.38	0.40	-7.05
Income Tax Expense	2.11	-4.74	-0.50	3.31	0.40	18	-5.54	5.12	3.22	4.26	7.06
Basic Earnings per Share	$0.10	($0.61)	($0.01)	$0.10	$0.06	($0.30)	$0.30	$0.36	$0.28	$0.87	$0.73
Weighted Average Basic Shares Outstanding	56.12M	55.94M	56.01K	55.88M	55.79M	55.72M	55.77M	55.71M	55.59M	55.46M	55.50M
Diluted Earnings per Share	$0.10	($0.61)	($0.01)	$0.10	$0.06	($0.29)	$0.30	$0.35	$0.27	$0.84	$0.71
Weighted Average Diluted Shares Outstanding	56.56M	55.94M	56.01K	56.43M	56.53M	56.38M	56.94M	56.86M	57.05M	57.46M	57.30M
Weighted Average Basic & Diluted Shares Outstanding	56.18M	56.15M	56.03M	56.01M	55.88M	55.77M	55.83M	55.76M	55.68M	55.56M	55.52M

This table details how cash moves in and out of Repligen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	6.03	228	-80	-113	180	341	20	51	68	19
Net Cash From Operating Activities	175	114	172	119	63	67	33	17	7.52	15
Net Cash From Continuing Operating Activities	175	114	172	119	58	65	33	17	7.52	15
Net Income / (Loss) Continuing Operations	-26	36	186	128	60	21	17	28	12	9.35
Consolidated Net Income / (Loss)	-26	36	186	128	60	21	17	28	12	9.35
Depreciation Expense	70	69	51	38	27	21	16	11	5.33	4.59
Amortization Expense	16	2.45	1.82	22	11	7.54	4.25	3.98	2.27	-
Non-Cash Adjustments To Reconcile Net Income	68	57	33	30	13	16	7.59	6.81	0.50	3.60
Changes in Operating Assets and Liabilities, net	47	-49	-100	-100	-53	-0.73	-11	-32	-12	-2.49
Net Cash From Investing Activities	-86	-123	-233	-221	-201	-205	-14	-99	-49	4.79
Net Cash From Continuing Investing Activities	-86	-123	-233	-221	-201	-205	-14	-99	-49	4.79
Purchase of Property, Plant & Equipment	-26	-36	-85	-67	-22	-19	-12	-5.45	-4.33	-2.63
Acquisitions	-62	-189	-49	-154	-179	-187	-2.15	-113	-45	-
Purchase of Investments	0.00	0.00	-100	0.00	0.00	-	-	-0.05	-24	-20
Sale and/or Maturity of Investments	0.00	102	0.00	0.00	-	-	-	20	23	28
Other Investing Activities, net	1.29	0.03	0.11	0.00	0.00	-	-	-	-	-
Net Cash From Financing Activities	-83	249	-13	0.96	306	485	3.41	130	112	0.77
Net Cash From Continuing Financing Activities	-83	249	-13	0.96	306	485	3.41	130	112	0.77
Repayment of Debt	-70	-7.30	-0.03	-0.02	0.00	-115	-0.01	-	-	-
Repurchase of Common Equity	0.00	-14	0.00	0.00	-	-	-	-	-	-
Issuance of Debt	0.00	290	0.00	0.00	-	278	0.00	-	111	-
Other Financing Activities, net	-13	-19	-13	0.98	8.14	0.68	3.42	0.64	1.84	0.87
Effect of Exchange Rate Changes	-0.08	-12	-5.87	-12	13	-3.19	-2.08	2.38	-2.30	-1.88
Cash Interest Paid	6.07	0.99	1.03	1.07	1.07	1.48	2.44	2.44	1.22	-
Cash Income Taxes Paid	19	27	34	17	10	6.51	4.05	4.02	3.99	4.95

This table details how cash moves in and out of Repligen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-60	-27	-25	29	29	121	27	87	-6.85	-50	-23
Net Cash From Operating Activities	15	39	49	42	45	29	39	34	11	62	41
Net Cash From Continuing Operating Activities	15	39	49	42	45	29	39	34	11	62	41
Net Income / (Loss) Continuing Operations	5.83	-34	2.94	6.92	3.30	-16	3.15	6.29	15	49	40
Consolidated Net Income / (Loss)	5.83	-34	2.94	6.92	3.30	-16	3.15	6.29	15	49	40
Depreciation Expense	19	18	18	17	17	17	20	16	15	14	13
Amortization Expense	4.04	-8.79	17	13	3.81	1.08	0.46	6.94	0.46	0.46	0.46
Non-Cash Adjustments To Reconcile Net Income	1.00	27	40	30	13	28	11	1.82	9.88	6.31	9.28
Changes in Operating Assets and Liabilities, net	-15	37	-28	-24	7.49	-1.06	4.77	3.19	-30	-7.99	-21
Net Cash From Investing Activities	-74	-65	-5.86	-7.40	-8.36	-170	-8.77	65	-9.43	-121	-57
Net Cash From Continuing Investing Activities	-74	-65	-5.86	-7.40	-8.36	-170	-8.77	65	-9.43	-121	-57
Purchase of Property, Plant & Equipment	-3.56	-5.54	-6.98	-4.81	-8.35	-11	-8.39	-8.24	-8.51	-20	-12
Acquisitions	-71	-59	-0.16	-2.59	-0.03	-159	-0.41	-29	-0.92	-0.94	-46
Sale of Property, Plant & Equipment	0.04	-	-	-	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	0.00	-	-	-	0.00	-	-	102	0.00	-	-
Net Cash From Financing Activities	-5.03	1.45	-70	-5.77	-8.97	268	-0.78	-8.83	-9.56	-0.27	1.25
Net Cash From Continuing Financing Activities	-5.03	1.45	-70	-5.77	-8.97	268	-0.78	-8.83	-9.56	-0.27	1.25
Repayment of Debt	0.00	-	-70	-0.17	-0.14	-7.25	-0.03	-0.01	0.00	-0.01	-
Other Financing Activities, net	-5.03	1.45	0.03	-5.61	-8.84	-0.33	-0.74	-8.81	-9.56	-0.27	1.25
Other Net Changes in Cash	4.01	-	-	-	-	-	-	-	-	-	-

This table presents Repligen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	2,830	2,831	2,532	2,358	1,903	1,400	775	744	289	146
Total Current Assets	1,066	1,111	998	932	902	642	276	243	184	103
Cash & Equivalents	757	751	523	604	717	528	194	174	122	54
Accounts Receivable	134	124	116	117	71	44	36	28	16	11
Inventories, net	143	202	238	184	95	55	42	39	25	18
Prepaid Expenses	32	34	20	26	19	5.92	3.90	2.28	1.64	2.10
Plant, Property, & Equipment, net	198	207	191	125	67	48	32	22	15	14
Total Noncurrent Assets	1,566	1,512	1,343	1,302	934	710	467	478	90	29
Goodwill	1,031	987	856	860	618	468	327	327	60	14
Intangible Assets	398	407	361	337	287	213	135	145	30	13
Noncurrent Deferred & Refundable Income Taxes	0.75	1.53	0.84	1.90	2.48	2.92	4.36	0.00	-	-
Other Noncurrent Operating Assets	136	117	126	102	26	26	0.17	6.23	-	-
Total Liabilities & Shareholders' Equity	2,830	2,831	2,532	2,358	1,903	1,400	775	744	289	146
Total Liabilities	857	866	621	608	374	340	159	152	120	23
Total Current Liabilities	127	165	404	375	319	48	130	25	21	19
Short-Term Debt	17	82	299	255	244	0.00	103	0.00	-	-
Accounts Payable	32	20	28	36	17	11	10	7.28	5.06	6.72
Accrued Expenses	62	57	71	75	53	33	16	18	16	12
Other Current Liabilities	15	5.63	6.96	8.30	5.25	3.56	-	-	-	-
Total Noncurrent Liabilities	730	701	217	233	55	292	29	127	99	4.71
Long-Term Debt	526	510	0.00	-	-	233	-	99	95	-
Noncurrent Deferred & Payable Income Tax Liabilities	23	39	23	33	27	30	25	25	2.10	-
Other Noncurrent Operating Liabilities	182	152	194	200	28	29	4.13	2.34	1.70	4.71
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,973	1,965	1,911	1,750	1,529	1,060	616	592	169	123
Total Preferred & Common Equity	1,973	1,965	1,911	1,750	1,529	1,060	616	592	169	123
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,973	1,965	1,911	1,750	1,529	1,060	616	592	169	123
Common Stock	1,618	1,570	1,548	1,573	1,461	1,069	643	629	242	203
Retained Earnings	407	433	397	194	66	5.84	-16	-32	-60	-72
Accumulated Other Comprehensive Income / (Loss)	-53	-38	-34	-17	2.09	-15	-12	-6.36	-14	-8.57

This table presents Repligen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,852	2,831	2,866	2,854	2,523	2,557	2,548	2,463
Total Current Assets	1,032	1,132	1,157	1,131	980	1,000	1,022	953
Cash & Equivalents	697	784	809	781	631	604	517	573
Accounts Receivable	147	129	123	116	106	120	133	118
Inventories, net	153	182	191	198	211	241	245	243
Prepaid Expenses	35	36	33	36	32	35	25	20
Plant, Property, & Equipment, net	196	203	205	206	202	203	193	174
Total Noncurrent Assets	1,624	1,496	1,505	1,517	1,341	1,355	1,334	1,335
Goodwill	1,082	988	986	986	869	871	856	851
Intangible Assets	409	381	386	394	350	358	353	360
Noncurrent Deferred & Refundable Income Taxes	0.74	0.10	0.68	0.87	1.55	1.76	0.85	1.76
Other Noncurrent Operating Assets	132	128	132	136	120	124	123	122
Total Liabilities & Shareholders' Equity	2,852	2,831	2,866	2,854	2,523	2,557	2,548	2,463
Total Liabilities	867	814	882	888	549	600	621	627
Total Current Liabilities	152	108	175	182	379	388	417	411
Short-Term Debt	34	14	83	94	299	302	313	298
Accounts Payable	27	21	21	19	19	24	26	25
Accrued Expenses	76	61	58	59	58	60	69	75
Other Current Liabilities	15	12	12	9.78	3.32	2.89	7.96	13
Total Noncurrent Liabilities	715	706	707	707	170	212	205	217
Long-Term Debt	530	522	518	514	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	24	34	34	37	15	22	22	23
Other Noncurrent Operating Liabilities	161	150	155	156	156	190	182	193
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,985	2,017	1,984	1,966	1,974	1,957	1,927	1,835
Total Preferred & Common Equity	1,985	2,017	1,984	1,966	1,974	1,957	1,927	1,835
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,985	2,017	1,984	1,966	1,974	1,957	1,927	1,835
Common Stock	1,620	1,610	1,587	1,572	1,568	1,562	1,546	1,542
Retained Earnings	413	441	442	436	449	432	413	349
Accumulated Other Comprehensive Income / (Loss)	-48	-35	-44	-43	-43	-37	-31	-55

This table displays calculated financial ratios and metrics derived from Repligen's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.33%	-21.11%	19.54%	83.08%	35.53%	39.28%	37.38%	-32.42%	150.17%	31.46%
EBITDA Growth	-63.68%	-55.38%	18.18%	111.87%	65.62%	38.67%	66.45%	22.36%	26.85%	20.23%
EBIT Growth	-188.23%	-77.62%	29.57%	141.26%	90.79%	36.26%	97.10%	-11.88%	13.48%	22.43%
NOPAT Growth	-182.09%	-84.29%	36.43%	97.77%	139.18%	46.65%	-63.23%	243.29%	66.54%	22.19%
Net Income Growth	-171.68%	-80.86%	44.95%	114.08%	179.88%	28.85%	-41.39%	142.73%	25.00%	14.38%
EPS Growth	-173.02%	-80.56%	44.64%	101.80%	152.27%	18.92%	-48.61%	111.76%	21.43%	12.00%
Operating Cash Flow Growth	53.97%	-33.80%	44.59%	90.05%	-6.83%	105.11%	87.78%	132.03%	-50.04%	-18.19%
Free Cash Flow Firm Growth	112.31%	-2,964.87%	103.23%	10.28%	-14.70%	-1,776.49%	103.51%	-497.74%	-671.25%	186.01%
Invested Capital Growth	-2.66%	13.91%	13.13%	32.77%	39.79%	43.77%	1.59%	324.48%	149.14%	-0.79%
Revenue Q/Q Growth	2.99%	-5.59%	0.03%	13.14%	11.98%	29.98%	-15.08%	-38.50%	108.17%	6.44%
EBITDA Q/Q Growth	-50.03%	-31.04%	1.26%	17.80%	13.21%	2.12%	11.42%	11.23%	24.59%	6.25%
EBIT Q/Q Growth	-481.76%	-54.40%	6.48%	13.66%	18.94%	-6.10%	22.40%	0.75%	14.08%	7.80%
NOPAT Q/Q Growth	-590.68%	-68.48%	8.03%	6.56%	34.90%	-5.01%	-34.48%	37.53%	80.16%	11.04%
Net Income Q/Q Growth	-30.99%	-68.92%	11.79%	7.92%	36.72%	-8.67%	-28.25%	33.72%	68.87%	7.64%
EPS Q/Q Growth	-39.39%	-68.50%	11.72%	6.67%	35.37%	-12.00%	-28.85%	22.03%	78.95%	3.70%
Operating Cash Flow Q/Q Growth	6.12%	-22.36%	7.67%	41.24%	-4.28%	22.00%	-22.77%	316.79%	-15.67%	11.88%
Free Cash Flow Firm Q/Q Growth	120.32%	-9,817.70%	118.27%	48.82%	-3,065.94%	1.40%	-55.98%	13.48%	-154.90%	21.51%
Invested Capital Q/Q Growth	-0.58%	9.04%	1.67%	4.09%	29.92%	0.30%	1.28%	0.40%	49.13%	-3.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.29%	44.03%	56.85%	58.35%	57.23%	55.93%	55.40%	52.53%	77.45%	57.80%
EBITDA Margin	6.80%	18.78%	33.20%	33.58%	29.02%	23.75%	23.85%	19.68%	10.87%	21.44%
Operating Margin	-5.53%	7.54%	28.03%	24.94%	19.06%	13.35%	13.39%	9.92%	7.64%	16.48%
EBIT Margin	-6.64%	7.55%	26.61%	24.55%	18.63%	13.24%	13.53%	9.43%	7.23%	15.94%
Profit (Net Income) Margin	-4.02%	5.63%	23.20%	19.13%	16.36%	7.92%	8.56%	20.07%	5.59%	11.19%
Tax Burden Percent	94.37%	62.77%	84.86%	83.55%	101.20%	81.87%	77.52%	391.18%	99.91%	69.62%
Interest Burden Percent	64.17%	118.76%	102.73%	93.26%	86.77%	73.11%	81.66%	54.42%	77.36%	100.78%
Effective Tax Rate	0.00%	37.23%	15.14%	16.45%	-1.20%	18.13%	22.48%	-291.18%	0.09%	30.38%
Return on Invested Capital (ROIC)	-1.38%	1.77%	12.77%	11.37%	7.80%	4.61%	3.87%	17.15%	18.70%	19.52%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.88%	-0.57%	14.16%	14.16%	10.56%	8.73%	8.15%	60.67%	25.78%	19.87%
Return on Net Nonoperating Assets (RNNOA)	0.08%	0.07%	-2.61%	-3.55%	-3.18%	-2.06%	-1.11%	-9.69%	-10.68%	-11.55%
Return on Equity (ROE)	-1.30%	1.84%	10.16%	7.82%	4.63%	2.56%	2.75%	7.46%	8.01%	7.97%
Cash Return on Invested Capital (CROIC)	1.32%	-11.24%	0.45%	-16.78%	-25.38%	-31.30%	2.29%	-106.58%	-66.73%	20.31%
Operating Return on Assets (OROA)	-1.49%	1.78%	8.73%	7.73%	4.13%	3.29%	3.46%	2.58%	6.95%	9.70%
Return on Assets (ROA)	-0.90%	1.33%	7.61%	6.02%	3.63%	1.97%	2.19%	5.49%	5.37%	6.81%
Return on Common Equity (ROCE)	-1.30%	1.84%	10.16%	7.82%	4.63%	2.56%	2.75%	7.46%	8.01%	7.97%
Return on Equity Simple (ROE_SIMPLE)	-1.29%	1.81%	9.73%	7.33%	3.92%	2.02%	2.70%	4.79%	6.92%	7.61%
Net Operating Profit after Tax (NOPAT)	-25	30	191	140	71	30	20	55	16	9.58
NOPAT Margin	-3.87%	4.74%	23.79%	20.84%	19.29%	10.93%	10.38%	38.79%	7.64%	11.47%
Net Nonoperating Expense Percent (NNEP)	-0.50%	2.34%	-1.39%	-2.79%	-2.76%	-4.12%	-4.28%	-43.52%	-7.08%	-0.35%
Return On Investment Capital (ROIC_SIMPLE)	-0.98%	1.17%	8.63%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	56.71%	55.97%	43.15%	41.65%	42.77%	44.07%	44.60%	47.47%	22.55%	42.20%
SG&A Expenses to Revenue	41.51%	34.57%	26.93%	27.42%	32.66%	35.38%	33.86%	36.47%	14.76%	29.57%
R&D to Revenue	6.81%	6.76%	5.48%	5.11%	5.51%	7.20%	8.15%	6.14%	3.52%	6.87%
Operating Expenses to Revenue	48.82%	36.49%	28.82%	33.41%	38.17%	42.58%	42.01%	42.61%	-30.14%	41.33%
Earnings before Interest and Taxes (EBIT)	-42	48	213	165	68	36	26	13	15	13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	43	119	266	225	106	64	46	28	23	18
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.09	5.11	4.92	8.37	6.59	4.54	3.76	2.67	6.18	7.59
Price to Tangible Book Value (P/TBV)	14.83	17.59	13.53	26.51	16.17	12.71	15.08	13.23	13.13	9.74
Price to Revenue (P/Rev)	12.71	15.87	11.73	21.84	27.53	17.82	11.92	11.19	4.99	11.16
Price to Earnings (P/E)	0.00	282.01	50.55	114.14	168.26	224.91	139.20	55.75	4.73	99.73
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.35%	1.98%	0.88%	0.59%	0.44%	0.72%	1.79%	21.15%	1.00%
Enterprise Value to Invested Capital (EV/IC)	4.47	5.47	5.72	10.20	9.10	5.97	4.23	2.91	8.18	17.56
Enterprise Value to Revenue (EV/Rev)	12.37	15.62	11.32	21.32	26.24	16.69	11.46	10.66	4.77	10.28
Enterprise Value to EBITDA (EV/EBITDA)	182.00	83.20	34.10	63.48	90.42	70.29	48.03	54.17	43.84	47.93
Enterprise Value to EBIT (EV/EBIT)	0.00	206.90	42.54	86.82	140.82	126.11	84.68	113.08	65.91	64.46
Enterprise Value to NOPAT (EV/NOPAT)	0.00	329.94	47.60	102.29	136.00	152.69	110.34	27.49	62.42	89.60
Enterprise Value to Operating Cash Flow (EV/OCF)	44.76	86.73	52.74	120.10	153.45	67.11	67.83	86.30	132.45	57.04
Enterprise Value to Free Cash Flow (EV/FCFF)	334.54	0.00	1,363.80	0.00	0.00	0.00	186.00	0.00	0.00	86.11
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.30	0.16	0.15	0.16	0.22	0.17	0.17	0.56	0.00
Long-Term Debt to Equity	0.27	0.26	0.00	0.00	0.00	0.22	0.00	0.17	0.56	0.00
Financial Leverage	-0.09	-0.12	-0.18	-0.25	-0.30	-0.24	-0.14	-0.16	-0.41	-0.58
Leverage Ratio	1.44	1.38	1.34	1.30	1.28	1.30	1.26	1.36	1.49	1.17
Compound Leverage Factor	0.92	1.64	1.37	1.21	1.11	0.95	1.03	0.74	1.15	1.18
Debt to Total Capital	21.57%	23.17%	13.51%	12.73%	13.75%	18.01%	14.39%	14.37%	36.08%	0.00%
Short-Term Debt to Total Capital	0.68%	3.22%	13.51%	12.73%	13.75%	0.00%	14.39%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	20.89%	19.95%	0.00%	0.00%	0.00%	18.01%	0.00%	14.37%	36.08%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.43%	76.83%	86.49%	87.27%	86.25%	81.99%	85.61%	85.63%	63.92%	100.00%
Debt to EBITDA	12.58	4.99	1.12	1.13	2.29	3.63	2.24	3.57	4.19	0.00
Net Debt to EBITDA	-4.98	-1.34	-1.22	-1.55	-4.46	-4.75	-1.95	-2.68	-2.05	0.00
Long-Term Debt to EBITDA	12.19	4.30	0.00	0.00	0.00	3.63	0.00	3.57	4.19	0.00
Debt to NOPAT	-22.08	19.79	1.57	1.83	3.45	7.88	5.14	1.81	5.97	0.00
Net Debt to NOPAT	8.73	-5.30	-1.71	-2.49	-6.70	-10.31	-4.48	-1.36	-2.91	0.00
Long-Term Debt to NOPAT	-21.38	17.04	0.00	0.00	0.00	7.88	0.00	1.81	5.97	0.00
Altman Z-Score	6.42	7.85	10.18	15.36	16.92	9.28	9.29	6.78	6.49	24.69
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.41	6.74	2.47	2.48	2.83	13.28	2.12	9.63	8.74	5.50
Quick Ratio	7.03	5.31	1.83	1.92	2.47	11.84	1.77	7.99	7.49	4.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	23	-191	6.65	-206	-230	-200	12	-340	-57	9.97
Operating Cash Flow to CapEx	683.08%	314.50%	202.85%	177.40%	278.89%	363.25%	275.61%	319.97%	175.72%	572.79%
Free Cash Flow to Firm to Interest Expense	1.13	-12.56	5.73	-18.28	-21.34	-13.41	1.78	-52.86	-15.12	311.58
Operating Cash Flow to Interest Expense	8.46	7.51	148.09	10.55	5.82	4.50	4.88	2.71	2.00	470.41
Operating Cash Flow Less CapEx to Interest Expense	7.22	5.12	75.09	4.60	3.73	3.26	3.11	1.86	0.86	388.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.22	0.24	0.33	0.31	0.22	0.25	0.26	0.27	0.96	0.61
Accounts Receivable Turnover	4.91	5.26	6.86	7.10	6.37	6.81	6.11	6.45	15.25	8.62
Inventory Turnover	2.08	1.61	1.64	2.00	2.09	2.45	2.13	2.11	2.21	2.32
Fixed Asset Turnover	3.13	3.18	5.08	6.99	6.35	6.70	7.11	7.56	14.53	5.90
Accounts Payable Turnover	13.92	15.02	10.85	10.52	11.07	10.87	9.74	10.86	8.00	6.66
Days Sales Outstanding (DSO)	74.29	69.38	53.20	51.39	57.33	53.64	59.72	56.56	23.94	42.34
Days Inventory Outstanding (DIO)	175.14	227.19	223.10	182.66	174.60	148.78	171.40	173.38	165.37	157.29
Days Payable Outstanding (DPO)	26.22	24.30	33.65	34.69	32.98	33.58	37.48	33.60	45.65	54.81
Cash Conversion Cycle (CCC)	223.21	272.28	242.66	199.36	198.96	168.84	193.64	196.35	143.66	144.82
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,758	1,806	1,586	1,402	1,056	755	525	517	122	49
Invested Capital Turnover	0.36	0.37	0.54	0.55	0.40	0.42	0.37	0.44	2.45	1.70
Increase / (Decrease) in Invested Capital	-48	221	184	346	300	230	8.20	395	73	-0.39
Enterprise Value (EV)	7,850	9,880	9,076	14,294	9,610	4,511	2,223	1,506	996	859
Market Capitalization	8,064	10,039	9,401	14,643	10,083	4,815	2,313	1,581	1,043	932
Book Value per Share	$35.21	$35.19	$34.41	$31.65	$29.06	$20.36	$14.04	$13.58	$4.99	$3.73
Tangible Book Value per Share	$9.71	$10.22	$12.51	$9.99	$11.85	$7.28	$3.50	$2.74	$2.35	$2.90
Total Capital	2,515	2,557	2,209	2,005	1,773	1,293	719	691	264	123
Total Debt	543	593	299	255	244	233	103	99	95	0.00
Total Long-Term Debt	526	510	0.00	0.00	0.00	233	0.00	99	95	0.00
Net Debt	-215	-159	-325	-349	-474	-305	-90	-75	-47	-73
Capital Expenditures (CapEx)	26	36	85	67	22	19	12	5.45	4.28	2.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)	199	278	269	208	110	56	56	44	21	13
Debt-free Net Working Capital (DFNWC)	956	1,029	892	812	827	594	249	218	163	84
Net Working Capital (NWC)	939	946	594	556	583	594	146	218	163	84
Net Nonoperating Expense (NNE)	0.93	-5.65	4.69	11	11	8.13	3.53	26	4.28	0.24
Net Nonoperating Obligations (NNO)	-215	-159	-325	-349	-474	-305	-90	-75	-47	-74
Total Depreciation and Amortization (D&A)	85	71	53	61	38	28	20	14	7.61	4.59
Debt-free, Cash-free Net Working Capital to Revenue	31.37%	43.89%	33.53%	31.00%	30.00%	20.76%	28.64%	31.02%	10.19%	15.20%
Debt-free Net Working Capital to Revenue	150.74%	162.70%	111.35%	121.05%	225.84%	219.62%	128.53%	154.05%	78.03%	101.12%
Net Working Capital to Revenue	148.04%	149.66%	74.10%	82.98%	159.29%	219.62%	75.19%	154.05%	78.03%	101.12%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.46)	$0.00	$3.35	$2.33	$1.14	$0.44	$0.38	$0.74	$0.35	$0.28
Adjusted Weighted Average Basic Shares Outstanding	55.94M	0.00	55.46M	55.02M	52.55M	48.34M	43.77M	38.23M	33.57M	32.88M
Adjusted Diluted Earnings per Share	($0.46)	$0.00	$3.24	$2.24	$1.11	$0.44	$0.37	$0.72	$0.34	$0.28
Adjusted Weighted Average Diluted Shares Outstanding	55.94M	0.00	57.46M	57.26M	53.89M	49.21M	45.47M	39.15M	34.10M	33.58M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.15M	0.00	55.56M	55.33M	54.77M	52.08M	43.92M	43.59M	33.85M	33.03M
Normalized Net Operating Profit after Tax (NOPAT)	-22	11	166	145	49	30	20	9.80	19	12
Normalized NOPAT Margin	-3.52%	1.70%	20.74%	21.57%	13.34%	10.93%	10.38%	6.94%	9.19%	14.87%
Pre Tax Income Margin	-4.26%	8.97%	27.34%	22.90%	16.17%	9.68%	11.05%	5.13%	5.59%	16.07%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.03	3.15	183.58	14.60	6.34	2.39	3.91	2.07	4.01	416.22
NOPAT to Interest Expense	-1.19	1.97	164.07	12.39	6.56	1.98	3.00	8.51	4.24	299.45
EBIT Less CapEx to Interest Expense	-3.27	0.76	110.58	8.65	4.25	1.16	2.14	1.22	2.88	334.09
NOPAT Less CapEx to Interest Expense	-2.42	-0.41	91.07	6.44	4.48	0.74	1.23	7.66	3.10	217.33
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.83%	1.06%
Augmented Payout Ratio	0.00%	40.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.83%	1.06%

This table displays calculated financial ratios and metrics derived from Repligen's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.44%	0.56%	9.69%	-0.21%	-7.38%	-10.78%	-29.66%	-23.34%	-19.87%	0.13%	12.64%
EBITDA Growth	15.21%	-213.26%	13.68%	-18.95%	-30.22%	-56.10%	-56.35%	-40.84%	-58.98%	5.43%	2.49%
EBIT Growth	2,285.50%	-523.11%	-200.59%	-75.54%	-102.00%	-80.11%	-88.76%	-67.38%	-77.21%	35.78%	2.73%
NOPAT Growth	44.34%	70.66%	-178.60%	-77.40%	-70.80%	-293.89%	-84.44%	-70.94%	-76.05%	43.64%	22.10%
Net Income Growth	76.88%	-105.89%	-103.86%	-71.13%	-78.51%	-133.76%	-58.12%	-60.32%	-67.34%	67.40%	20.62%
EPS Growth	66.67%	-110.34%	-103.33%	-71.43%	-77.78%	-134.52%	-57.75%	-60.23%	-66.67%	68.00%	22.41%
Operating Cash Flow Growth	-66.44%	34.79%	25.72%	22.40%	300.82%	-53.03%	-5.16%	-24.61%	-51.74%	24.71%	83.99%
Free Cash Flow Firm Growth	66.91%	107.31%	-30.55%	10.21%	-42.13%	-121.22%	46.49%	61.58%	66.81%	55.80%	66.20%
Invested Capital Growth	3.35%	-2.66%	6.76%	7.27%	10.49%	13.91%	6.22%	9.64%	8.63%	13.13%	15.81%
Revenue Q/Q Growth	0.97%	8.18%	0.52%	4.95%	-1.64%	18.01%	-11.29%	-12.86%	-11.45%	-6.96%	-3.32%
EBITDA Q/Q Growth	189.83%	-209.30%	35.42%	85.15%	18.53%	9.69%	-28.59%	-8.73%	-54.26%	9.07%	-18.26%
EBIT Q/Q Growth	114.19%	-703.55%	-785.77%	338.13%	72.15%	91.03%	-73.67%	-37.32%	-72.63%	7.94%	-23.10%
NOPAT Q/Q Growth	118.90%	-366.05%	-675.29%	72.05%	638.74%	-1,348.46%	-54.91%	-38.65%	-74.50%	0.19%	-14.95%
Net Income Q/Q Growth	117.21%	-5,078.75%	-119.69%	172.83%	112.93%	-197.21%	-15.65%	-31.37%	-68.53%	20.60%	-18.96%
EPS Q/Q Growth	116.39%	-6,000.00%	-116.67%	150.00%	113.64%	-196.67%	-14.29%	-31.37%	-67.86%	18.31%	-19.32%
Operating Cash Flow Q/Q Growth	-61.70%	-20.57%	16.90%	-5.63%	53.82%	-25.91%	13.82%	209.02%	-81.98%	49.59%	-9.52%
Free Cash Flow Firm Q/Q Growth	-345.35%	119.16%	-9.50%	26.65%	26.72%	-242.07%	37.57%	-10.68%	15.64%	17.25%	50.38%
Invested Capital Q/Q Growth	5.33%	-0.58%	-0.51%	-1.19%	-1.14%	9.04%	-0.77%	1.21%	2.28%	1.67%	3.30%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.65%	23.18%	50.03%	51.33%	50.13%	47.10%	25.89%	50.17%	50.51%	51.44%	56.90%
EBITDA Margin	16.92%	-19.02%	18.82%	21.70%	13.35%	16.88%	18.16%	26.71%	17.72%	34.31%	29.26%
Operating Margin	3.89%	-21.79%	-5.06%	3.44%	2.45%	5.93%	3.32%	12.11%	8.38%	26.15%	26.24%
EBIT Margin	3.48%	-24.73%	-3.33%	2.98%	-0.18%	5.88%	3.63%	12.16%	8.15%	26.37%	22.73%
Profit (Net Income) Margin	3.45%	-20.21%	-0.42%	3.60%	2.15%	-9.87%	11.99%	12.43%	9.27%	26.09%	20.13%
Tax Burden Percent	73.40%	87.73%	56.92%	63.29%	89.20%	-882.04%	148.70%	79.45%	82.65%	91.97%	85.12%
Interest Burden Percent	135.11%	93.17%	22.28%	190.68%	-1,373.61%	19.04%	221.98%	128.69%	137.68%	107.61%	104.05%
Effective Tax Rate	26.60%	0.00%	0.00%	36.71%	10.80%	982.04%	-48.70%	20.55%	17.35%	8.03%	14.88%
Return on Invested Capital (ROIC)	1.02%	-5.43%	-1.27%	0.77%	0.80%	-19.49%	2.06%	4.44%	3.38%	12.91%	12.32%
ROIC Less NNEP Spread (ROIC-NNEP)	0.37%	-0.97%	-2.94%	-0.11%	0.82%	-48.68%	-1.21%	2.94%	2.04%	11.77%	13.69%
Return on Net Nonoperating Assets (RNNOA)	-0.03%	0.09%	0.43%	0.01%	-0.10%	6.08%	0.19%	-0.47%	-0.32%	-2.17%	-2.48%
Return on Equity (ROE)	0.99%	-5.34%	-0.85%	0.79%	0.70%	-13.41%	2.25%	3.97%	3.06%	10.74%	9.83%
Cash Return on Invested Capital (CROIC)	-4.54%	1.32%	-6.75%	-6.98%	-8.41%	-11.24%	-0.12%	-1.00%	1.63%	0.45%	-2.51%
Operating Return on Assets (OROA)	0.79%	-5.54%	-0.77%	0.67%	-0.04%	1.39%	0.98%	3.55%	2.51%	8.64%	7.74%
Return on Assets (ROA)	0.79%	-4.53%	-0.10%	0.81%	0.50%	-2.33%	3.23%	3.63%	2.86%	8.55%	6.86%
Return on Common Equity (ROCE)	0.99%	-5.34%	-0.85%	0.79%	0.70%	-13.41%	2.25%	3.97%	3.06%	10.74%	9.83%
Return on Equity Simple (ROE_SIMPLE)	-1.16%	0.00%	-0.97%	0.04%	1.50%	0.00%	5.76%	7.04%	8.01%	0.00%	9.06%
Net Operating Profit after Tax (NOPAT)	4.83	-26	-5.48	3.46	3.35	-87	6.98	15	11	45	45
NOPAT Margin	2.85%	-15.25%	-3.54%	2.18%	2.18%	-52.26%	4.94%	9.62%	6.93%	24.05%	22.33%
Net Nonoperating Expense Percent (NNEP)	0.65%	-4.46%	1.66%	0.88%	-0.02%	29.19%	3.27%	1.50%	1.34%	1.13%	-1.37%
Return On Investment Capital (ROIC_SIMPLE)	0.19%	-1.02%	-	-	-	-3.41%	-	-	-	2.03%	-
Cost of Revenue to Revenue	46.35%	76.82%	49.97%	48.67%	49.87%	52.90%	74.11%	49.83%	49.49%	48.56%	43.10%
SG&A Expenses to Revenue	42.12%	36.09%	48.82%	41.22%	40.35%	34.59%	39.37%	30.84%	34.04%	28.51%	26.72%
R&D to Revenue	7.64%	6.97%	6.27%	6.66%	7.34%	6.17%	7.49%	6.10%	7.35%	5.95%	5.10%
Operating Expenses to Revenue	49.76%	44.97%	55.09%	47.88%	47.68%	41.18%	22.57%	38.06%	42.13%	25.29%	30.67%
Earnings before Interest and Taxes (EBIT)	5.88	-41	-5.16	4.73	-0.27	9.79	5.13	19	13	49	46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	29	-32	29	34	20	28	26	43	29	64	59
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.60	4.09	4.13	3.55	5.22	5.11	4.46	4.03	4.86	4.92	5.66
Price to Tangible Book Value (P/TBV)	14.47	14.83	12.86	11.49	17.55	17.59	11.43	10.82	13.05	13.53	16.64
Price to Revenue (P/Rev)	10.98	12.71	13.53	11.60	16.39	15.87	13.24	10.80	12.30	11.73	12.96
Price to Earnings (P/E)	0.00	0.00	0.00	9,159.58	347.66	282.01	77.40	57.18	60.61	50.55	62.69
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.01%	0.29%	0.35%	1.29%	1.75%	1.65%	1.98%	1.60%
Enterprise Value to Invested Capital (EV/IC)	3.79	4.47	4.57	3.85	5.63	5.47	5.15	4.58	5.58	5.72	6.48
Enterprise Value to Revenue (EV/Rev)	10.78	12.37	13.13	11.26	16.11	15.62	12.74	10.39	11.90	11.32	12.61
Enterprise Value to EBITDA (EV/EBITDA)	149.45	182.00	93.70	76.70	86.81	83.20	49.55	35.74	40.40	34.10	38.46
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	957.11	246.98	206.90	81.49	52.21	53.98	42.54	50.45
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	10,997.55	378.73	329.94	89.83	58.39	58.71	47.60	57.27
Enterprise Value to Operating Cash Flow (EV/OCF)	48.12	44.76	48.93	44.05	68.46	86.73	58.16	50.88	56.52	52.74	63.24
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	334.54	0.00	0.00	0.00	0.00	0.00	0.00	357.07	1,363.80	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.28	0.27	0.30	0.31	0.30	0.15	0.15	0.16	0.16	0.16
Long-Term Debt to Equity	0.27	0.27	0.26	0.26	0.26	0.26	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.08	-0.09	-0.15	-0.13	-0.12	-0.12	-0.16	-0.16	-0.16	-0.18	-0.18
Leverage Ratio	1.44	1.44	1.33	1.38	1.39	1.38	1.30	1.33	1.34	1.34	1.32
Compound Leverage Factor	1.95	1.34	0.30	2.62	-19.06	0.26	2.89	1.71	1.84	1.44	1.38
Debt to Total Capital	22.11%	21.57%	20.98%	23.25%	23.62%	23.17%	13.05%	13.37%	13.97%	13.51%	13.96%
Short-Term Debt to Total Capital	1.33%	0.68%	0.55%	3.23%	3.65%	3.22%	13.05%	13.37%	13.97%	13.51%	13.96%
Long-Term Debt to Total Capital	20.78%	20.89%	20.44%	20.02%	19.97%	19.95%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	77.89%	78.43%	79.02%	76.75%	76.38%	76.83%	86.95%	86.63%	86.03%	86.49%	86.04%
Debt to EBITDA	12.01	12.58	6.21	6.74	5.23	4.99	1.73	1.42	1.40	1.12	1.13
Net Debt to EBITDA	-2.85	-4.98	-2.88	-2.33	-1.49	-1.34	-1.93	-1.42	-1.36	-1.22	-1.05
Long-Term Debt to EBITDA	11.29	12.19	6.04	5.81	4.42	4.30	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-24.93	-22.08	-150.48	967.14	22.80	19.79	3.14	2.33	2.03	1.57	1.69
Net Debt to NOPAT	5.92	8.73	69.80	-334.64	-6.48	-5.30	-3.50	-2.33	-1.98	-1.71	-1.56
Long-Term Debt to NOPAT	-23.43	-21.38	-146.57	832.94	19.28	17.04	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.75	6.42	7.01	5.64	7.77	7.80	10.95	8.71	9.86	9.97	10.78
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.79	8.41	10.44	6.62	6.23	6.74	2.69	2.57	2.45	2.47	2.32
Quick Ratio	5.56	7.03	8.43	5.33	4.94	5.31	2.03	1.86	1.80	1.83	1.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-55	22	-117	-117	-167	-308	-90	-130	-117	-139	-168
Operating Cash Flow to CapEx	426.16%	707.15%	706.29%	877.50%	535.68%	262.15%	467.82%	418.30%	131.08%	302.69%	350.15%
Free Cash Flow to Firm to Interest Expense	-10.51	4.12	-22.93	-22.84	-33.16	-22.05	-220.46	-316.69	-287.57	-515.12	-510.89
Operating Cash Flow to Interest Expense	2.86	7.17	9.63	8.24	8.89	2.08	96.15	83.86	27.34	229.19	125.74
Operating Cash Flow Less CapEx to Interest Expense	2.19	6.16	8.27	7.30	7.23	1.29	75.60	63.82	6.48	153.47	89.83
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.23	0.22	0.23	0.22	0.23	0.24	0.27	0.29	0.31	0.33	0.34
Accounts Receivable Turnover	4.94	4.91	5.24	4.99	5.03	5.26	5.99	6.04	5.94	6.86	6.69
Inventory Turnover	2.06	2.08	1.62	1.61	1.57	1.61	1.57	1.41	1.51	1.64	1.69
Fixed Asset Turnover	3.24	3.13	3.05	2.98	3.15	3.18	3.56	3.93	4.47	5.08	5.85
Accounts Payable Turnover	15.85	13.92	15.84	15.50	15.44	15.02	16.13	10.55	10.68	10.85	12.62
Days Sales Outstanding (DSO)	73.84	74.29	69.67	73.21	72.60	69.38	60.98	60.39	61.41	53.20	54.59
Days Inventory Outstanding (DIO)	177.12	175.14	225.16	227.23	231.87	227.19	232.46	258.88	242.30	223.10	215.88
Days Payable Outstanding (DPO)	23.03	26.22	23.05	23.54	23.64	24.30	22.63	34.61	34.18	33.65	28.93
Cash Conversion Cycle (CCC)	227.93	223.21	271.78	276.90	280.83	272.28	270.80	284.67	269.53	242.66	241.55
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,852	1,758	1,768	1,775	1,792	1,806	1,656	1,655	1,622	1,586	1,559
Invested Capital Turnover	0.36	0.36	0.36	0.35	0.37	0.37	0.42	0.46	0.49	0.54	0.55
Increase / (Decrease) in Invested Capital	60	-48	112	120	170	221	97	145	129	184	213
Enterprise Value (EV)	7,011	7,850	8,086	6,836	10,096	9,880	8,534	7,575	9,049	9,076	10,107
Market Capitalization	7,144	8,064	8,335	7,044	10,269	10,039	8,866	7,876	9,355	9,401	10,383
Book Value per Share	$35.36	$35.21	$36.01	$35.52	$35.23	$35.19	$35.67	$35.14	$34.68	$34.41	$33.07
Tangible Book Value per Share	$8.80	$9.71	$11.58	$10.97	$10.49	$10.22	$13.91	$13.07	$12.90	$12.51	$11.25
Total Capital	2,549	2,515	2,552	2,586	2,573	2,557	2,287	2,259	2,240	2,209	2,133
Total Debt	563	543	536	601	608	593	299	302	313	299	298
Total Long-Term Debt	530	526	522	518	514	510	0.00	0.00	0.00	0.00	0.00
Net Debt	-134	-215	-248	-208	-173	-159	-332	-302	-305	-325	-276
Capital Expenditures (CapEx)	3.52	5.54	6.98	4.81	8.35	11	8.39	8.24	8.51	20	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	217	199	253	256	263	278	283	310	300	269	267
Debt-free Net Working Capital (DFNWC)	914	956	1,037	1,065	1,043	1,029	914	913	918	892	840
Net Working Capital (NWC)	880	939	1,023	982	950	946	615	612	605	594	543
Net Nonoperating Expense (NNE)	-1.00	8.32	-4.83	-2.25	0.05	-71	-9.95	-4.47	-3.88	-3.82	4.42
Net Nonoperating Obligations (NNO)	-134	-215	-248	-209	-174	-159	-332	-302	-305	-325	-276
Total Depreciation and Amortization (D&A)	23	9.58	34	30	21	18	21	23	16	15	13
Debt-free, Cash-free Net Working Capital to Revenue	33.38%	31.37%	41.10%	42.20%	41.94%	43.89%	42.23%	42.48%	39.45%	33.53%	33.30%
Debt-free Net Working Capital to Revenue	140.57%	150.74%	168.36%	175.48%	166.52%	162.70%	136.41%	125.25%	120.71%	111.35%	104.85%
Net Working Capital to Revenue	135.37%	148.04%	166.10%	161.74%	151.55%	149.66%	91.83%	83.86%	79.57%	74.10%	67.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.10	($0.61)	($0.01)	$0.10	$0.06	($0.30)	$0.33	$0.00	$0.00	$0.87	$0.73
Adjusted Weighted Average Basic Shares Outstanding	56.12M	55.94M	56.01K	55.88M	55.79M	55.72M	55.77M	0.00	0.00	55.46M	55.50M
Adjusted Diluted Earnings per Share	$0.10	($0.61)	($0.01)	$0.10	$0.06	($0.29)	$0.32	$0.00	$0.00	$0.84	$0.71
Adjusted Weighted Average Diluted Shares Outstanding	56.56M	55.94M	56.01K	56.43M	56.53M	56.38M	56.94M	0.00	0.00	57.46M	57.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.18M	56.15M	56.03M	56.01M	55.88M	55.77M	55.83M	0.00	0.00	55.56M	55.52M
Normalized Net Operating Profit after Tax (NOPAT)	4.83	-23	-5.48	3.46	3.35	7.40	-21	17	12	29	43
Normalized NOPAT Margin	2.85%	-13.92%	-3.54%	2.18%	2.18%	4.44%	-14.68%	10.52%	7.54%	15.62%	21.35%
Pre Tax Income Margin	4.70%	-23.04%	-0.74%	5.68%	2.41%	1.12%	8.06%	15.65%	11.22%	28.37%	23.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.12	-7.59	-1.01	0.93	-0.05	0.70	12.57	47.09	33.03	182.37	138.66
NOPAT to Interest Expense	0.92	-4.68	-1.07	0.68	0.67	-6.24	17.10	37.27	28.07	166.35	136.26
EBIT Less CapEx to Interest Expense	0.45	-8.60	-2.37	-0.01	-1.71	-0.09	-7.99	27.04	12.18	106.65	102.75
NOPAT Less CapEx to Interest Expense	0.25	-5.69	-2.43	-0.26	-0.99	-7.04	-3.46	17.22	7.22	90.63	100.35
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	40.41%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Repligen's Financials

When does Repligen's financial year end?

According to the most recent income statement we have on file, Repligen's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Repligen's net income changed over the last 9 years?

Repligen's net income appears to be on an upward trend, with a most recent value of -$25.51 million in 2024, falling from $9.35 million in 2015. The previous period was $35.60 million in 2023. See where experts think Repligen is headed by visiting Repligen's forecast page.

What is Repligen's operating income?

Repligen's total operating income in 2024 was -$35.11 million, based on the following breakdown:

Total Gross Profit: $274.65 million
Total Operating Expenses: $309.76 million

How has Repligen revenue changed over the last 9 years?

Over the last 9 years, Repligen's total revenue changed from $83.54 million in 2015 to $634.44 million in 2024, a change of 659.5%.

How much debt does Repligen have?

Repligen's total liabilities were at $856.95 million at the end of 2024, a 1.1% decrease from 2023, and a 3,548.3% increase since 2015.

How much cash does Repligen have?

In the past 9 years, Repligen's cash and equivalents has ranged from $54.09 million in 2015 to $757.36 million in 2024, and is currently $757.36 million as of their latest financial filing in 2024.

How has Repligen's book value per share changed over the last 9 years?

Over the last 9 years, Repligen's book value per share changed from 3.73 in 2015 to 35.21 in 2024, a change of 845.0%.

Related Companies

This page (NASDAQ:RGEN) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Repligen (RGEN) Financials

Frequently Asked Questions About Repligen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Repligen (RGEN) Financials

Annual Income Statements for Repligen

Quarterly Income Statements for Repligen

Annual Cash Flow Statements for Repligen

Quarterly Cash Flow Statements for Repligen

Annual Balance Sheets for Repligen

Quarterly Balance Sheets for Repligen

Annual Metrics And Ratios for Repligen

Quarterly Metrics And Ratios for Repligen

Frequently Asked Questions About Repligen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools